Natural Language Processing for Radiation Oncology: Personalizing Treatment Pathways.

Publication Year: 2024

DOI:
10.2147/PGPM.S396971

PMCID:
PMC10874185

PMID:
38370334

Journal Information

Full Title: Pharmgenomics Pers Med

Abbreviation: Pharmgenomics Pers Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure JH: Research Funding from American Cancer Society, American Society for Clinical Oncology/Conquer Cancer Foundation, American Society for Radiation Oncology, National Institutes of Health/National Cancer Institute, Prostate Cancer Foundation, Radiation Oncology Institute, Roche. HL: Research Funding from DOD, Uncle Kory Foundation. The authors report no other conflicts of interest in this work."

Evidence found in paper:

"Disclosure: JH: Research Funding from American Cancer Society, American Society for Clinical Oncology/Conquer Cancer Foundation, American Society for Radiation Oncology, National Institutes of Health/National Cancer Institute, Prostate Cancer Foundation, Radiation Oncology Institute, Roche. HL: Research Funding from DOD, Uncle Kory Foundation. The authors report no other conflicts of interest in this work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025